Durect Corp financial data

Symbol
DRRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
10240 Bubb Road, Cupertino, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 111 % -49.7%
Quick Ratio 7.23 % -17.1%
Return On Equity -217 % -66.1%
Return On Assets -50.4 % +11.3%
Operating Margin -380 % -92.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31 M shares +26.8%
Common Stock, Shares, Outstanding 30.3 M shares +33.1%
Entity Public Float 120 M USD +11.5%
Common Stock, Value, Issued 23 K USD 0%
Weighted Average Number of Shares Outstanding, Basic 30.6 M shares +28.9%
Weighted Average Number of Shares Outstanding, Diluted 30.6 M shares +28%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 8.32 M USD -54%
Research and Development Expense 24.9 M USD -33.2%
Costs and Expenses 39.9 M USD -27.7%
Operating Income (Loss) -31.6 M USD +11.6%
Nonoperating Income (Expense) 8.3 M USD -99.6%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -23.3 M USD +36.2%
Earnings Per Share, Basic -0.8 USD/shares +49%
Earnings Per Share, Diluted -0.93 USD/shares +41.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.3 M USD -51%
Accounts Receivable, after Allowance for Credit Loss, Current 1.02 M USD -27.2%
Inventory, Net 2.4 M USD +8.46%
Assets, Current 26.1 M USD -48.4%
Property, Plant and Equipment, Net 58 K USD -59.7%
Operating Lease, Right-of-Use Asset 3.63 M USD +137%
Goodwill 6.17 M USD 0%
Other Assets, Noncurrent 128 K USD
Assets 36.2 M USD -37.9%
Accounts Payable, Current 782 K USD -61%
Accrued Liabilities, Current 5.11 M USD -30.9%
Contract with Customer, Liability, Current 178 K USD
Liabilities, Current 24.7 M USD -41.2%
Contract with Customer, Liability, Noncurrent 812 K USD 0%
Operating Lease, Liability, Noncurrent 2.47 M USD
Other Liabilities, Noncurrent 716 K USD -22.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -10 K USD -42.9%
Retained Earnings (Accumulated Deficit) -597 M USD -4.06%
Stockholders' Equity Attributable to Parent 8.3 M USD -45.9%
Liabilities and Equity 36.2 M USD -37.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.77 M USD +27%
Net Cash Provided by (Used in) Financing Activities -1.5 M USD -115%
Net Cash Provided by (Used in) Investing Activities -887 K USD +82%
Common Stock, Shares Authorized 150 M shares 0%
Common Stock, Shares, Issued 30.3 M shares +33.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.4 M USD -50.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.33 M USD +29.6%
Deferred Tax Assets, Valuation Allowance 123 M USD +4.89%
Deferred Tax Assets, Gross 124 M USD +5.37%
Operating Lease, Liability 4.08 M USD +95.2%
Depreciation 148 K USD -1.33%
Payments to Acquire Property, Plant, and Equipment 52 K USD -53.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -23.3 M USD +36.1%
Lessee, Operating Lease, Liability, to be Paid 4.54 M USD +161%
Property, Plant and Equipment, Gross 15 M USD -22.3%
Operating Lease, Liability, Current 1.3 M USD -21.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.44 M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.4 M USD +409%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 903 K USD +490%
Lessee, Operating Lease, Liability, to be Paid, Year Three 432 K USD
Deferred Tax Assets, Operating Loss Carryforwards 83.8 M USD +0.59%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10 M shares 0%
Unrecognized Tax Benefits 13.6 M USD +3.83%
Lessee, Operating Lease, Liability, to be Paid, Year Four 227 K USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 51 K USD +15.9%
Share-based Payment Arrangement, Expense 2.45 M USD +2.69%
Interest Expense 2.4 M USD +11.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%